Cannabidiol or CBD are the non-psychoactive components of Hemp and cannabis.  Non-psychoactive means they are not mind altering.  CBDs do have a neurological response, in fact they have many responses.  You see, there are Cannabinoid Receptors in the brain.  Our brains actually have something termed an endocannabinoid system.  The endocannabinoid system (ECS) is made up of endogenous cannabinoid receptors.  The Cannabinoid Receptors are comprised of two parts: The Neuromodulatory Lipids and their Receptors. The ECS is  located in the mammalian brain and is runs through the central and peripheral nervous systems.  The ECS is often referred to as  “the body’s own cannabinoid system”, the ECS affects pain sensitivity, the appetite, memory, and mood.  Ok and here’s a fun fact: CBDs actually counter the effects of THC on the brain.

Many endocannabinoid receptors are present in the brain, two primary receptors have been identified: CB1 and CB2. CB1 receptors are prevalent in the nervous system and the brain.  However the CB1 receptors are also present in peripheral organs and tissues.

So, let’s recap.  CBDs are not psychoactive.  You don’t get high from using CBDs.  Our brains have an endocannabinoid system that tracks through our brain and nervous system.  CBDs are the only compound that stimulate neuro-chemical reactions in our ECS.  CBDs are proving to have wide ranging medical benefits that are being used to treat severe seizure conditions, skin conditions, Parkinson’s, strokes, and other traumatic brain injuries.  The future of CBDs in medicine is certain.  The only question is to what extent and how far ranging are the conditions they will treat.

Join us for our follow up article next week on the difference between FDA approved CBDs currently on the market and the CBDs being used in these studies and being offered in the medical dispensaries around the world.